Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

DNA interstrand cross-linking agents and their chemotherapeutic potential.

Brulikova L, Hlavac J, Hradil P.

Curr Med Chem. 2012;19(3):364-85. Review.

PMID:
22335513
2.
3.

The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy.

Guohui S, Lijiao Z, Rugang Z.

Anticancer Agents Med Chem. 2015;16(2):221-46. Review.

PMID:
26299659
4.

Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.

Hartinger CG, Phillips AD, Nazarov AA.

Curr Top Med Chem. 2011;11(21):2688-702. Review.

PMID:
22039871
5.

Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.

Muchova T, Quintal SM, Farrell NP, Brabec V, Kasparkova J.

J Biol Inorg Chem. 2012 Feb;17(2):239-45. doi: 10.1007/s00775-011-0845-0. Epub 2011 Sep 21.

PMID:
21938443
6.

FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.

Beckerbauer L, Tepe JJ, Cullison J, Reeves R, Williams RM.

Chem Biol. 2000 Oct;7(10):805-12.

7.

Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.

Kaspárková J, Nováková O, Vrána O, Farrell N, Brabec V.

Biochemistry. 1999 Aug 24;38(34):10997-1005.

PMID:
10460154
8.

Preparation of interstrand cross-linked DNA oligonucleotide duplexes.

Noll DM, Noronha AM, Wilds CJ, Miller PS.

Front Biosci. 2004 Jan 1;9:421-37. Review.

PMID:
14766379
9.

DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.

Brabec V, Kaspárková J, Vrána O, Nováková O, Cox JW, Qu Y, Farrell N.

Biochemistry. 1999 May 25;38(21):6781-90.

PMID:
10346899
10.

Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.

Clingen PH, Arlett CF, Hartley JA, Parris CN.

Exp Cell Res. 2007 Feb 15;313(4):753-60. Epub 2006 Nov 18.

PMID:
17188678
11.
12.

[Cross-linked nucleic acids: formation, structure, and biological function].

Efimov VA, Fediunin SV, Chakhmakhcheva OG.

Bioorg Khim. 2010 Jan-Feb;36(1):56-80. Review. Russian.

PMID:
20386579
13.
14.

Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.

Wang K, Gao E.

Anticancer Agents Med Chem. 2014 Jan;14(1):147-69. Review.

PMID:
23869783
15.

DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].

Brabec V, Christofis P, Slámová M, Kostrhunová H, Nováková O, Najajreh Y, Gibson D, Kaspárková J.

Biochem Pharmacol. 2007 Jun 15;73(12):1887-900. Epub 2007 Mar 12.

PMID:
17400194
16.

The development of bis(hydroxymethyl)pyrrole analogs as bifunctional DNA cross-linking agents and their chemotherapeutic potential.

Su TL, Lee TC, Kakadiya R.

Eur J Med Chem. 2013 Nov;69:609-21. doi: 10.1016/j.ejmech.2013.09.016. Epub 2013 Sep 18. Review.

PMID:
24095754
17.

Flanking sequences modulate diepoxide and mustard cross-linking efficiencies at the 5'-GNC site.

Sawyer GA, Frederick ED, Millard JT.

Chem Res Toxicol. 2004 Aug;17(8):1057-63.

PMID:
15310237
18.
20.

Effect of nucleosome structure on DNA interstrand cross-linking reactions.

Millard JT, Spencer RJ, Hopkins PB.

Biochemistry. 1998 Apr 14;37(15):5211-9.

PMID:
9548752

Supplemental Content

Support Center